Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission
β Scribed by Livio Trentin; Giovanni Pizzolo; Cristina Feruglio; Renato Zambello; Maria Masciarelli; Pietro Bulian; Carlo Agostini; Fabrizio Vinante; Roberta Zanotti; Gianpietro Semenzato
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 582 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Potential cure of acute myeloid leukemia (AML) is now a widely accepted idea, but it is uncertain whether there is heterogeneity in the failure rate in patients once they have been in complete remission (CR) for various periods of time. ## METHODS. The longβterm outcom
## Abstract ## BACKGROUND: The optimal postremission therapy in adults with acute lymphoblastic leukemia (ALL) is still a matter of debate. The objective of this study was to compare the various potential therapeutic options for patients who achieved first complete remission. ## METHODS: The aut
We describe 3 patients with acute myeloblastic leukemia (AML), who received rhG-CSF for infections such as pneumonia or for prophylaxis of infection, and who achieved complete remission. They had not received any antileukemic therapy before or during the administration of rhG-CSF. These findings sug